Acadia Healthcare Reaffirms Commitment to Value Creation

09/24/2025 – 11:49 AM

FRANKLIN, Tenn. – Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a leading provider in behavioral healthcare services, reaffirmed its commitment to long-term shareholder value creation in a statement released today. The company’s board of directors and management team emphasized ongoing communication with shareholders and a receptiveness to constructive input regarding the company’s strategic direction.

Acadia’s core mission remains centered on establishing a benchmark for excellence in the treatment of behavioral health and substance use disorders. The company is pursuing a focused strategy that prioritizes disciplined growth to expand access to high-quality behavioral healthcare across its nationwide network. This includes strengthening clinical outcomes and driving operational efficiencies.

Beyond organic growth, Acadia is actively optimizing its portfolio to enhance cash flow generation while concurrently bolstering its financial position. This strategic financial management is intended to support sustainable, long-term growth and maximize value for all shareholders.

The Board of Directors is continuously evaluating all opportunities to enhance shareholder value, reinforcing its commitment to Acadia’s mission of improving the lives of individuals in need of behavioral healthcare.

Acadia has tapped Goldman Sachs and J.P. Morgan as financial advisors, and Kirkland & Ellis LLP as legal advisor.

About Acadia

Acadia Healthcare operates a network of 274 behavioral healthcare facilities with approximately 12,100 beds across 39 states and Puerto Rico, according to data from June 30, 2025. Employing roughly 25,000 individuals and serving over 82,000 patients daily, Acadia stands as the largest independent behavioral healthcare company in the U.S. The company delivers a spectrum of behavioral healthcare services through inpatient psychiatric hospitals, specialized treatment centers, residential facilities, and outpatient clinics.

Forward-Looking Information

This announcement includes forward-looking statements as defined under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements encompass projections related to Acadia’s strategy, future growth, anticipated operating results, and share repurchase programs. These statements are generally identified by the use of terms like “may,” “will,” “should,” “could,” “anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,” and “believe” or their negative counterparts, and other similar expressions. These are based on the company’s current expectations as of the release date, and Acadia does not commit to updating or revising these statements in response to new information or future events.

These forward-looking statements are subject to inherent risks and uncertainties, which could cause actual results to deviate substantially from those expressed or implied. Key factors include: (i) challenges in integrating acquired facilities or realizing the expected benefits and synergies from expansions, acquisitions, joint ventures, and de novo transactions; (ii) Acadia’s success in expanding services, adding beds, enhancing marketing, and improving efficiencies; (iii) potential reductions in payments from government and commercial payors, potentially impacted by the One Big Beautiful Bill Act (“OBBBA”) of July 4, 2025; (iv) patient incidents, governmental investigations, litigation, and adverse regulatory actions; (v) the risk that Acadia may not generate sufficient cash from operations; (vi) disruptions to IT systems or cybersecurity incidents; and (vii) potential operating difficulties, influenced by an evolving U.S. economic and financial landscape; reduced admissions; increased labor, supply chain, and other costs. Changes in competition and client preferences, or industry conditions, may prevent Acadia from realizing its strategic objectives. For a more comprehensive description of these and other factors, refer to Acadia’s Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent reports filed with the Securities and Exchange Commission.

While Acadia’s strategic initiatives appear sound, the behavioral healthcare market is facing increasing pressures related to reimbursement models and operational costs. Specifically, analysts at CNBC highlight that potential changes stemming from the OBBBA legislation introduce uncertainty regarding Medicaid funding, a crucial source of revenue for Acadia. Furthermore, the company’s ability to effectively integrate new facilities and manage operational efficiencies will be critical in maintaining profitability and shareholder value amidst these evolving industry dynamics.